![Leigh Hsu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leigh Hsu
Corporate Officer/Principal bij CARSGEN THERAPEUTICS HOLDINGS LIMITED
Actieve functies van Leigh Hsu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CARSGEN THERAPEUTICS HOLDINGS LIMITED | Corporate Officer/Principal | 01-06-2017 | - |
Loopbaan van Leigh Hsu
Eerdere bekende functies van Leigh Hsu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - | - |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 19-02-2013 | - |
Opleiding van Leigh Hsu
University of California San Diego | Doctorate Degree |
University of California, Irvine | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 5 |
China | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |